A5070652334- SARS-CoV-2 and COVID-19 Research
- Vascular Procedures and Complications
- Dialysis and Renal Disease Management
- Systemic Sclerosis and Related Diseases
- Immunodeficiency and Autoimmune Disorders
- COVID-19 Clinical Research Studies
- COVID-19 epidemiological studies
- Central Venous Catheters and Hemodialysis
Chulabhorn Hospital
2020-2023
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) increases mortality rates in older adults and those with comorbidities. Individuals certain comorbidities may have a poor immune response require early booster vaccines. We aimed to assess the after two doses of ChAdOx1 nCoV-19 vaccine, at 84-day intervals, participants following comorbidities; diabetes mellitus; obesity; cardiovascular disease; chronic kidney rheumatological cirrhosis; hematological malignancy; or solid...
There is currently a controversy for the optimal vascular access option in elderly, regarding their multiple comorbidities and life expectancies. Our study aimed to compare survival of tunneled cuff venous catheter (CVC) arteriovenous (AV access) elderly patients.A retrospective cohort was performed by electronic medical record review. All hemodialysis patients aged 65 years over who firstly initiated dialysis from January 1, 2012 December 31, 2016 at Siriraj hospital, Thailand, were...